共 20 条
- [2] Should Newer Oral Anticoagulants Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation and Risk Factors for Stroke or Thromboembolism? New Oral Anticoagulants Should Not Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation [J]. CIRCULATION, 2012, 125 (01) : 165 - 170
- [6] Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban The Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation [J]. STROKE, 2014, 45 (05) : 1304 - 1312
- [8] January CT, 2014, CIRCULATION, V130, pE199, DOI 10.1161/CIR.0000000000000041